top of page

TRANSVAC: a pillar of vaccine development in Europe for 16 years
The European vaccine development ecosystem has been strengthened over the last 16 years, thanks to the EVI-led TRANSVAC project, an...
Jan 31

Launch of TRANSVAC Academy for Vaccine Researchers and Developers
We are thrilled to announce TRANSVAC Academy, a programme providing advanced training in specific vaccinology subjects by leading experts.
Aug 30, 2024


Virus-like particles herald the next generation of polio vaccines
January 2024 Despite global vaccination programs reaching the brink of poliomyelitis eradication, the disease is still endemic...
Jan 25, 2024

TRANSAVC2 concludes: key achievements and new horizons
July 2023 The Final meeting of the TRANSVAC2 project was held in a hybrid form on 19-20 April 2023 in Brussels. Over 50 attendees...
Jul 20, 2023

ISIDORe Preparedness Programme Calls for Proposals are Open for Applications
ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has announced the launch of its preparedness programme calls for...
Nov 18, 2022

Open call for vaccinology training courses
Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills, know-how and technical...
Nov 15, 2022


TRANSVAC at International Conference on Research Infrastructures 2022
Dr Stefan Jungbluth, EVI Head of Business Development, represented TRANSVAC in the 'International Conference on Research Infrastructures...
Nov 2, 2022


TRANSVAC featured in Merck Future Talk Podcast
What do firefighters and vaccine development have in common? Check out the Merck Future Talk Podcast episode on '#TRANSVAC and the Future...
Sep 25, 2022


TRANSVAC2 and TRANSVAC-DS joint annual meeting brought together partners in Frankfurt
The TRANSVAC Annual Meeting successfully took place on 6-7 September in Frankfurt (DE), including sessions on both TRANSVAC2 and...
Sep 8, 2022

A dose of teamwork against pandemics: TRANSVAC
Collaboration is key to developing vaccines. Merck's article highlights why collaboration in vaccine manufacturing learning is key to...
Mar 31, 2022


New publication: A gaps-and-needs analysis of vaccine R&D in Europe
What are the gaps and needs of vaccine R&D in Europe? TRANSVAC, European vaccine research infrastructure initiative, set out to find...
Feb 28, 2022

ISIDORe: A new approach to pandemic preparedness research in Europe
ISIDORe – “Integrated Services for Infectious Disease Outbreak Research” was officially launched today. The 21M€ EU-funded large-scale...
Feb 24, 2022


Open call: TRANSVAC2 November Newsletter is out!
Don't miss the latest open calls! Learn how TRANSVAC2 partners are successfully supporting vaccine development and get to know more...
Nov 18, 2021


EVI signs MoU with CEPI
The European Vaccine Initiative (EVI), as coordinator of the TRANSVAC2 vaccine research infrastructure, and the Coalition for Epidemic...
Jun 23, 2021

Open call: TRANSVAC2 Newsletter is out
Don't miss the latest news on open calls, events and opportunities! Learn how TRANSVAC2 partners are successfully using TRANSVAC2 R&D...
Jun 22, 2021

Apply for TRANSVAC2 Vaccine Development Training: Open call until June 1st, 2021!
TRANSVAC2 offers training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.
Apr 30, 2021

Open call: TRANSVAC Newsletter is out!
Don't miss the latest news on open calls, events and opportunities! Learn how TRANSVAC2 partners are successfully using TRANSVAC2 R&D...
Mar 3, 2021


Webinar: Regulatory information for veterinary vaccine development in the EU and where to find it
This webinar will be jointly organized by TRANSVAC and ENOVA and will be open to interested people working in the field of veterinary...
Oct 27, 2020


TRANSVAC October Newsletter is out!
Learn how partners are successfully using TRANSVAC2 R&D services and get to know more about what types of services are offered by TRANSVAC
Oct 15, 2020
Accelerating vaccine development for the fight against COVID-19
Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts in Europe and Worldwide.
Jul 9, 2020
bottom of page